{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:20:29Z","timestamp":1792718429661,"version":"4.5.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/md.0b013e3182431ef6","type":"journal-article","created":{"date-parts":[[2011,12,30]],"date-time":"2011-12-30T01:35:19Z","timestamp":1325208919000},"page":"57-66","source":"Crossref","is-referenced-by-count":426,"title":["Rituximab for the Treatment of IgG4-Related Disease"],"prefix":"10.1097","volume":"91","author":[{"given":"Arezou","family":"Khosroshahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mollie N.","family":"Carruthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Unizony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald B.","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210309","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2010.30.0673","article-title":". American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases.","volume":"28","author":"Artz","year":"2010","journal-title":"J Clin Oncol"},{"key":"R2-7-20210309","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":". M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"R3-7-20210309","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cgh.2006.05.017","article-title":". Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.","volume":"4","author":"Chari","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R4-7-20210309","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/PAP.0b013e3181ee63ce","article-title":"IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity.","volume":"17","author":"Cheuk","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"R5-7-20210309","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1111\/j.1572-0241.2007.01531.x","article-title":". Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series.","volume":"102","author":"Church","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R6-7-20210309","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/acr.20215","article-title":"Riedels thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum.","volume":"62","author":"Dahlgren","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R7-7-20210309","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/PAS.0b013e318213889e","article-title":"Eosinophilic angiocentric fibrosis is a form of IgG4-related systemic disease.","volume":"35","author":"Deshpande","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R9-7-20210309","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/BOR.0b013e328338f6df","article-title":"The A, B, Cs of viral hepatitis in the biologic era.","volume":"22","author":"Ferri","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"R10-7-20210309","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/PAS.0b013e3181c811ad","article-title":". Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease.","volume":"34","author":"Geyer","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R11-7-20210309","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1136\/gut.2007.129833","article-title":"Optimising corticosteroid treatment for autoimmune pancreatitis.","volume":"56","author":"Ghazale","year":"2007","journal-title":"Gut"},{"key":"R12-7-20210309","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":". A new clinicopathological entity of IgG4-related autoimmune disease.","volume":"38","author":"Kamisawa","year":"2003","journal-title":"J Gastroenterol"},{"key":"R13-7-20210309","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00535-006-1862-6","article-title":"Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease.","volume":"41","author":"Kamisawa","year":"2006","journal-title":"J Gastroenterol"},{"key":"R14-7-20210309","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gut.2008.172908","article-title":". Standard steroid treatment for autoimmune pancreatitis.","volume":"58","author":"Kamisawa","year":"2009","journal-title":"Gut"},{"key":"R15-7-20210309","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrgastro.2010.81","article-title":"Autoimmune pancreatitis and IgG4-related sclerosing disease.","volume":"7","author":"Kamisawa","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R17-7-20210309","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1002\/art.23059","article-title":". Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis.","volume":"56","author":"Keystone","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R18-7-20210309","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3816\/CLML.2010.n.034","article-title":"Treatment with bortezomib of a patient having hyper IgG4 disease.","volume":"10","author":"Khan","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R19-7-20210309","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.27435","article-title":"Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease.","volume":"62","author":"Khosroshahi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R20-7-20210309","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/BOR.0b013e3283418057","article-title":"A clinical overview of IgG4-related systemic disease.","volume":"23","author":"Khosroshahi","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"R21-7-20210309","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/BOR.0b013e328341a229","article-title":"IgG4-related systemic disease: the age of discovery.","volume":"23","author":"Khosroshahi","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"R22-7-20210309","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/BOR.0b013e328341a240","article-title":"Treatment approaches to IgG4-related systemic disease.","volume":"23","author":"Khosroshahi","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"R23-7-20210309","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0140-6736(09)60615-2","article-title":"Painless jaundice with serial multi-organ dysfunction.","volume":"373","author":"Khosroshahi","year":"2009","journal-title":"Lancet"},{"key":"R24-7-20210309","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.yexcr.2011.02.005","article-title":"BAFF inhibition: A new class of drugs for the treatment of autoimmunity.","volume":"317","author":"Liu","year":"2011","journal-title":"Exp Cell Res"},{"key":"R26-7-20210309","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2169\/internalmedicine.48.2695","article-title":". Autoimmune pancreatitis associated with various extrapancreatic lesions during a long-term clinical course successfully treated with azathioprine and corticosteroid maintenance therapy.","volume":"48","author":"Naitoh","year":"2009","journal-title":"Intern Med"},{"key":"R27-7-20210309","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/MPA.0b013e3181b9ee1c","article-title":". Japanese clinical guidelines for autoimmune pancreatitis.","volume":"38","author":"Okazaki","year":"2009","journal-title":"Pancreas"},{"key":"R28-7-20210309","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00535-008-2205-6","article-title":". Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis.","volume":"43","author":"Otsuki","year":"2008","journal-title":"J Gastroenterol"},{"key":"R29-7-20210309","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJM198906013202206","article-title":". The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem).","volume":"320","author":"Rock","year":"1989","journal-title":"N Engl J Med"},{"key":"R30-7-20210309","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/BOR.0b013e328341347b","article-title":"Pathological features of IgG4-related sclerosing disease.","volume":"23","author":"Smyrk","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"R31-7-20210309","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1002\/art.24798","article-title":"IgG4-related systemic disease and lymphoplasmacytic aortitis.","volume":"60","author":"Stone","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R32-7-20210309","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.cgh.2007.12.020","article-title":". Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis.","volume":"6","author":"Topazian","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R33-7-20210309","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3899\/jrheum.090856","article-title":". Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials.","volume":"37","author":"van Vollenhoven","year":"2010","journal-title":"J Rheumatol"},{"key":"R34-7-20210309","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","article-title":"IgG4-related disease: a cross-sectional study of 114 cases.","volume":"34","author":"Zen","year":"2010","journal-title":"Am J Surg Pathol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0b013e3182431ef6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:32:22Z","timestamp":1786048342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201201000-00007"}},"subtitle":["Lessons From 10 Consecutive Patients"],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3182431ef6","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}